beer and semaglutide Alcohol: What's Safe and What to Avoid Drinking Alcohol on GLP-1 Medications

can help explain why these medications are transforming obesity treatment and metabolic health

Urate as a predictor of the rate of clinical decline in Parkinson disease

Collectively, current evidence supports a model [Figure 1B] in which: (1) a large fraction of early MASH resolution in ESSENCE is likely explained by significant weight loss and associated metabolic reprogramming

The decision to continue or discontinue GLP-1 therapy should be made with your healthcare provider based on your individual risk factors, response to treatment, and long-term health goals

J Clin Microbiol 1999;37: 2625 2630

The oversimplification of GLP-1s on social media has transformed medicine into a fad, leaving users unprepared for the side effects and enchanted by the allure of advertising